Home
People
Research
Publications
Links
Contact
Funding
RSS Feed
Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults.
Revaz Machaidze
January 1, 2009
«
Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Rapid Selection of Cyclic Peptides that Reduce Alpha-Synuclein Toxicity in Yeast and Animal Models.
»
News & Events
Craniopharyngioma Trial Continues Enrollment
DRAMATIC CLINICAL RESPONSE TO PD-1 BLOCKADE IN MMR DEFICIENT HIGH-GRADE MENINGIOMA
GERMLINE AND SOMATIC BAP1 MUTATIONS IN HIGH GRADE MENINGIOMA.
HIGHLY MULTIPLEXED IMAGING OF HUMAN TISSUES
Molecular Margins with Metabolite Guide Brain Surgery
PIK3CA MUTATIONS IN MENINGIOMA
TARGETED THERAPY FOR PAPILLARY CRANIOPHARYNGIOMA
Top
